{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:38:11Z","timestamp":1791477491641,"version":"4.3.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009157","name":"U.S. Department of Health & Human Services | ACL | National Institute on Disability, Independent Living, and Rehabilitation Research","doi-asserted-by":"publisher","award":["90DPHF0009"],"award-info":[{"award-number":["90DPHF0009"]}],"id":[{"id":"10.13039\/100009157","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Spinal Cord"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Study design<\/jats:title>\n                <jats:p>Cross-sectional cohort study.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>To examine: (1) the self-reported frequency of specific prescription benzodiazepine use, (2) concurrent benzodiazepine and opioid use, and (3) sociodemographic, SCI, and opioid use factors associated with frequent benzodiazepine use.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Setting<\/jats:title>\n                <jats:p>Community.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Participants included 918 community dwelling adults with chronic (\u2009&gt;\u20091 year) traumatic SCI originally identified from a specialty hospital or a state-based surveillance system. Self-reported frequency of specific prescription benzodiazepines and opioids used, concurrent use, and factors associated with use were assessed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Twenty percent reported any benzodiazepine use in the past year and 13% reported at least weekly use. Concurrent daily or weekly use of benzodiazepines and opioids was reported by 6.5%, with those individuals taking an average of 1.1 (0.4) benzodiazepines and 1.4 (0.6) opioids. Compared to younger adults, those 50\u201365 years old had lower odds of at least weekly benzodiazepine use (OR\u2009=\u20090.50, 95% CI, 0.29\u20130.89, <jats:italic>p<\/jats:italic>-value\u2009=\u20090.02). Non-Hispanic Blacks reported lower use of benzodiazepines compared to non-Hispanic whites (OR\u2009=\u20090.32, 95% CI, 0.15\u20130.68, <jats:italic>p<\/jats:italic>-value\u2009=\u2009&lt;0.01). Weekly opioid use was associated with higher odds of using benzodiazepines (OR\u2009=\u20093.10, 95%CI, 1.95\u20134.95, <jats:italic>p<\/jats:italic>-value\u2009=\u2009&lt;0.01).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Benzodiazepine use was commonly reported among those with SCI. Despite the potential risks, a high portion of those who reported benzodiazepine use also reported prescription opioid use. The findings highlight the need for monitoring of prescription medication use to avoid potentially risky concurrent use and adverse outcomes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s41393-024-01030-4","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T10:03:11Z","timestamp":1726221791000},"page":"667-673","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Self-reported benzodiazepine use among adults with chronic spinal cord injury in the southeastern USA: associations with demographic, injury, and opioid use characteristics"],"prefix":"10.1038","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1459-4690","authenticated-orcid":false,"given":"Nicole D.","family":"DiPiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara E.","family":"Dismuke-Greer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8129-5389","authenticated-orcid":false,"given":"James S.","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,13]]},"reference":[{"key":"1030_CR1","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/pds.1304","volume":"16","author":"H Tobi","year":"2007","unstructured":"Tobi H, Faber A, van den Berg PB, Drane JW, de Jong-van den Berg LT. Studying co-medication patterns: the impact of definitions. Pharmacoepidemiol Drug Saf. 2007;16:405\u201311.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1030_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3390\/pharmacy6020043","volume":"6","author":"AV Fuentes","year":"2018","unstructured":"Fuentes AV, Pineda MD, Venkata KCN. Comprehension of top 200 prescribed drugs in the us as a resource for pharmacy teaching, training and practice. Pharmacy. 2018;6:43.","journal-title":"Pharmacy"},{"key":"1030_CR3","doi-asserted-by":"publisher","first-page":"e2028557","DOI":"10.1001\/jamanetworkopen.2020.28557","volume":"3","author":"KY Xu","year":"2020","unstructured":"Xu KY, Hartz SM, Borodovsky JT, Bierut LJ, Grucza RA. Association between benzodiazepine use with or without opioid use and all-cause mortality in the United States, 1999-2015. JAMA Netw Open. 2020;3:e2028557.","journal-title":"JAMA Netw Open"},{"key":"1030_CR4","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1038\/s41393-018-0174-z","volume":"56","author":"SJT Guilcher","year":"2018","unstructured":"Guilcher SJT, Hogan ME, Calzavara A, Hitzig SL, Patel T, Packer T, et al. Prescription drug claims following a traumatic spinal cord injury for older adults: a retrospective population-based study in Ontario, Canada. Spinal Cord. 2018;56:1059\u201368.","journal-title":"Spinal Cord"},{"key":"1030_CR5","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1080\/10790268.2021.1920786","volume":"46","author":"S Gupta","year":"2023","unstructured":"Gupta S, McColl MA, Smith K, McColl A. Prescribing patterns for treating common complications of spinal cord injury. J Spinal Cord Med. 2023;46:237\u201345.","journal-title":"J Spinal Cord Med"},{"key":"1030_CR6","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.apmr.2020.10.128","volume":"102","author":"ND DiPiro","year":"2021","unstructured":"DiPiro ND, Murday D, Corley EH, DiPiro TV, Krause JS. Opioid use among individuals with spinal cord injury: prevalence estimates based on state prescription drug monitoring program data. Arch Phys Med Rehabil. 2021;102:828\u201334.","journal-title":"Arch Phys Med Rehabil"},{"key":"1030_CR7","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.apmr.2017.12.004","volume":"99","author":"BN Hand","year":"2018","unstructured":"Hand BN, Krause JS, Simpson KN. Dose and duration of opioid use in propensity score-matched, privately insured opioid users with and without spinal cord injury. Arch Phys Med Rehabil. 2018;99:855\u201361.","journal-title":"Arch Phys Med Rehabil"},{"key":"1030_CR8","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1093\/pm\/pnad073","volume":"24","author":"JA Shoup","year":"2023","unstructured":"Shoup JA, Welter J, Binswanger IA, Hess F, Dullenkopf A, Coker J, et al. Spinal cord injury and prescribed opioids for pain: a scoping review. Pain Med. 2023;24:1138\u201352.","journal-title":"Pain Med"},{"key":"1030_CR9","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3390\/neurolint13040059","volume":"13","author":"AN Edinoff","year":"2021","unstructured":"Edinoff AN, Nix CA, Hollier J, Sagrera CE, Delacroix BM, Abubakar T, et al. Benzodiazepines: uses, dangers, and clinical considerations. Neurol Int. 2021;13:594\u2013607.","journal-title":"Neurol Int"},{"key":"1030_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1176\/appi.ps.201800321","volume":"70","author":"DT Maust","year":"2019","unstructured":"Maust DT, Lin LA, Blow FC. Benzodiazepine use and misuse among adults in the United States. Psychiatr Serv. 2019;70:97\u2013106.","journal-title":"Psychiatr Serv"},{"key":"1030_CR11","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41393-020-0511-x","volume":"59","author":"SJT Guilcher","year":"2021","unstructured":"Guilcher SJT, Hogan ME, McCormack D, Calzavara AJ, Hitzig SL, Patel T, et al. Prescription medications dispensed following a nontraumatic spinal cord dysfunction: a retrospective population-based study in Ontario, Canada. Spinal Cord. 2021;59:132\u201340.","journal-title":"Spinal Cord"},{"key":"1030_CR12","doi-asserted-by":"publisher","first-page":"885","DOI":"10.46747\/cfp.6812885","volume":"68","author":"MA McColl","year":"2022","unstructured":"McColl MA, Gupta S, McColl A, Smith K. Prescribing for common complications of spinal cord injury. Can Fam Physician. 2022;68:885\u20138.","journal-title":"Can Fam Physician"},{"key":"1030_CR13","doi-asserted-by":"publisher","first-page":"686","DOI":"10.2105\/AJPH.2016.303061","volume":"106","author":"MA Bachhuber","year":"2016","unstructured":"Bachhuber MA, Hennessy S, Cunningham CO, Starrels JL. Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996\u20132013. Am J Public Health. 2016;106:686\u20138.","journal-title":"Am J Public Health"},{"key":"1030_CR14","doi-asserted-by":"publisher","first-page":"j760","DOI":"10.1136\/bmj.j760","volume":"356","author":"EC Sun","year":"2017","unstructured":"Sun EC, Dixit A, Humphreys K, Darnall BD, Baker LC, Mackey S. Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis. BMJ. 2017;356:j760.","journal-title":"BMJ"},{"key":"1030_CR15","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.15585\/mmwr.mm7034a2","volume":"70","author":"S Liu","year":"2021","unstructured":"Liu S, O\u2019Donnell J, Gladden RM, McGlone L, Chowdhury F. Trends in nonfatal and fatal overdoses involving benzodiazepines - 38 states and the District of Columbia, 2019\u20132020. MMWR Morb Mortal Wkly Rep. 2021;70:1136\u201341.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1030_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","volume":"71","author":"D Dowell","year":"2022","unstructured":"Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC clinical practice guideline for prescribing opioids for pain - United States, 2022. MMWR Recomm Rep. 2022;71:1\u201395.","journal-title":"MMWR Recomm Rep"},{"key":"1030_CR17","first-page":"100130","volume":"5","author":"KK Marwitz","year":"2022","unstructured":"Marwitz KK, Noureldin M. A descriptive analysis of concomitant opioid and benzodiazepine medication use and associated adverse drug events in United States adults between 2009 and 2018. Explor Res Clin Soc Pharm. 2022;5:100130.","journal-title":"Explor Res Clin Soc Pharm"},{"key":"1030_CR18","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1080\/10790268.2022.2084931","volume":"46","author":"ND DiPiro","year":"2023","unstructured":"DiPiro ND, Murday D, Krause JS. Assessment of high-risk opioid use metrics among individuals with spinal cord injury: a brief report. J Spinal Cord Med. 2023;46:687\u201391.","journal-title":"J Spinal Cord Med"},{"key":"1030_CR19","unstructured":"National Survey on Drug Use and Health (NSDUH). The 2019 National Survey on Drug Use and Health: Center for Behavioral Health Statistics and Quality; [Available from: https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/reports\/rpt23057\/NSDUHmrbCAISpecs2019.pdf."},{"key":"1030_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.46292\/sci23-00050","volume":"30","author":"JS Krause","year":"2024","unstructured":"Krause JS, DiPiro ND, Dismuke-Greer CE. Self-reported prescription opioid use among participants with chronic spinal cord injury. Top Spinal Cord Inj Rehabil. 2024;30:131\u20139.","journal-title":"Top Spinal Cord Inj Rehabil"},{"key":"1030_CR21","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.eurpsy.2015.09.003","volume":"30","author":"TA Kurko","year":"2015","unstructured":"Kurko TA, Saastamoinen LK, Tahkapaa S, Tuulio-Henriksson A, Taiminen T, Tiihonen J, et al. Long-term use of benzodiazepines: Definitions, prevalence and usage patterns - a systematic review of register-based studies. Eur Psychiatry. 2015;30:1037\u201347.","journal-title":"Eur Psychiatry"},{"key":"1030_CR22","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1016\/j.mayocp.2016.07.024","volume":"91","author":"M Markota","year":"2016","unstructured":"Markota M, Rummans TA, Bostwick JM, Lapid MI. Benzodiazepine use in older adults: dangers, management, and alternative therapies. Mayo Clin Proc. 2016;91:1632\u20139.","journal-title":"Mayo Clin Proc"},{"key":"1030_CR23","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1001\/jamapsychiatry.2014.1763","volume":"72","author":"M Olfson","year":"2015","unstructured":"Olfson M, King M, Schoenbaum M. Benzodiazepine use in the United States. JAMA Psychiatry. 2015;72:136\u201342.","journal-title":"JAMA Psychiatry"},{"key":"1030_CR24","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41393-017-0050-2","volume":"56","author":"BN Hand","year":"2018","unstructured":"Hand BN, Krause JS, Simpson KN. Polypharmacy and adverse drug events among propensity score matched privately insured persons with and without spinal cord injury. Spinal Cord. 2018;56:591\u20137.","journal-title":"Spinal Cord"},{"key":"1030_CR25","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1179\/2045772314Y.0000000235","volume":"40","author":"P Kitzman","year":"2017","unstructured":"Kitzman P, Cecil D, Kolpek JH. The risks of polypharmacy following spinal cord injury. J Spinal Cord Med. 2017;40:147\u201353.","journal-title":"J Spinal Cord Med"},{"key":"1030_CR26","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.1080\/09638288.2019.1610085","volume":"42","author":"L Cadel","year":"2020","unstructured":"Cadel L, C Everall A, Hitzig SL, Packer TL, Patel T, Lofters A, et al. Spinal cord injury and polypharmacy: a scoping review. Disabil Rehabil. 2020;42:3858\u201370.","journal-title":"Disabil Rehabil"},{"key":"1030_CR27","doi-asserted-by":"crossref","unstructured":"Gupta S, Dhawan A, Dhawan J, McColl MA, Smith KM, McColl A. Potentially harmful drug-drug interactions in the therapeutic regimens of persons with spinal cord injury. J Spinal Cord Med. 2024;47:692\u2013700.","DOI":"10.1080\/10790268.2023.2185399"},{"key":"1030_CR28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.apmr.2008.07.012","volume":"90","author":"JS Krause","year":"2009","unstructured":"Krause JS, Carter RE, Pickelsimer E. Behavioral risk factors of mortality after spinal cord injury. Arch Phys Med Rehabil. 2009;90:95\u2013101.","journal-title":"Arch Phys Med Rehabil"},{"key":"1030_CR29","unstructured":"DiPiro N, Murday, D, Krause, J. Comparison of self-reported opioid and benzodiazepine usage to administrative data among adults with spinal cord injury: an analysis of self-report and prescription drug monitoring data from the South Carolina Reporting & Identification Prescription Tracking System (SCRIPTS). Under Development."},{"key":"1030_CR30","unstructured":"Krause JS, DiPiro ND, Dismuke-Greer CE, Cao Y. Relations Between Self-Reported Prescription Hydrocodone, Oxycodone, and Tramadol Use and Unintentional Injuries Among Those With Spinal Cord Injury. Arch Phys Med Rehabil. 2024:S0003-9993;01002\u20135."}],"container-title":["Spinal Cord"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41393-024-01030-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41393-024-01030-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41393-024-01030-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T09:03:35Z","timestamp":1731056615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41393-024-01030-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,13]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["1030"],"URL":"https:\/\/doi.org\/10.1038\/s41393-024-01030-4","relation":{},"ISSN":["1362-4393","1476-5624"],"issn-type":[{"value":"1362-4393","type":"print"},{"value":"1476-5624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,13]]},"assertion":[{"value":"26 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Approval was received from the Institutional Review Board at the Medical University of South Carolina. We certify that all applicable institutional and governmental regulations concerning the ethical use of human volunteers were followed during the course of this research. Informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}